昆药集团 (600422)

KPC Pharmaceuticals, Inc.

ASH

Tags

QFII Heavy PositionsSSE 380 IndexTraditional Chinese MedicineCSI Central State-Owned Enterprises IndexRural RevitalizationGeneric DrugsElderly Care ConceptPension FundsInnovative DrugsPharmaceutical ManufacturingPharmaceuticals and HealthcareIndustrial HempNew RetailMargin Trading and Securities LendingChina Securities Finance and Central Huijin Holdings

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 75697.58
  • Circulating A-Shares(W): 75697.58
  • Earnings Per Share(RMB): 0.3600
  • Net Assets Per Share(RMB): 7.0132
  • Operating Revenue(W RMB): 475120.61
  • Total Profit(W RMB): 37842.11
  • **Net Profit Attributable to Parent(W RMB) **: 26936.78
  • Net Profit Growth Rate(%): -30.47
  • Weighted Return on Equity(%): 5.0700
  • Operating Cash Flow Per Share(RMB): 0.2330
  • Undistributed Profit Per Share(RMB): 4.8312
  • Capital Reserve Per Share(RMB): 0.6879

2. Main Business

The main business covers:

  • Research, development, production and sales of natural botanical medicines

3. Company Basic Information

  • Company Name: Kunming Pharmaceutical Group
  • Listing Date: Unknown
  • Industry: Pharmaceutical Manufacturing
  • Address: Unknown
  • Website: Unknown
  • Company Profile: The company focuses on the research, development, production and sales of natural botanical medicines.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. General Legal Person 21231.16 28.05
2 Yunnan Hehe (Group) Co., Ltd. General Legal Person 5998.27 7.92
3 National Social Security Fund 406 Portfolio Social Security Fund 1435.13 1.90
4 Fullgoal Research Selected Flexible Allocation Mixed Securities Investment Fund Class A Fund 1389.26 1.84
5 Central Huijin Asset Management Co., Ltd. Special Legal Person 1181.49 1.56
6 Monetary Authority of Macao - Own Funds QFII 976.97 1.29
7 Hong Kong Securities Clearing Company Ltd. Northbound Capital 920.93 1.22
8 Invesco Great Wall Resource Monopoly Mixed Securities Investment Fund (LOF) Class A Fund 840.52 1.11
9 Kuwait Investment Authority - Own Funds QFII 638.11 0.84
10 Invesco Great Wall China Return Flexible Allocation Mixed Securities Investment Fund Class A Fund 572.77 0.76

5. Concept Sectors

  • Traditional Chinese Medicine
  • Pharmaceuticals

Remarks

  • Data update date: 2025-09-30
  • Data source: Public market information